�ڰ�������

New meta-analysis finds �ڰ�������’s non-invasive MRI biomarker cT1 is an effective alternative to biopsy for identifying patients at high risk of liver disease progression

�ڰ������� and HepQuant Announce Partnership to Bring a More Complete Picture of Liver Health

�ڰ������� Expands into Louisiana in Partnership with West Jefferson Medical Center in New Orleans, LA

�ڰ������� Announces Partnership with Datavant to Improve Clinical Trial Recruitment with Connected Data

New study finds �ڰ�������®’s LiverMultiScan® may positively impact patient participation in liver disease care pathways

First European guidance on the use of multiparametric MRI in fatty liver disease

Paige and �ڰ������� Partner to Power Late-Stage Clinical Trials with Digital Pathology

New Clinical Study Investigates Using Integrated Diagnostics to Enable Precision Medicine for Liver Cancer Patients

The National Consortium for Intelligent Medical Imaging COVID Research Fund supports �ڰ�������’s COVERSCAN study